Author

T. N. Alramadneh

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) develops within a chronically inflamed and immunologically dysregulated hepatic microenvironment that contributes to therapeutic resistance and disease progression. Gasdermin-mediated pyroptosis has emerged as a context-dependent inflammatory cell-death program capable of reshaping antitu...

T. Alramadneh, Inoyatillo Kholmurodov, Naina Boboyeva et al. · Clinical Immunology · 0 citations

Review Open access Aug 2026

Exosomal Non-Coding RNAs: Emerging regulators of the tumor microenvironment in gastrointestinal and hepatobiliary cancers.

Extracellular vesicle (EV)-associated non-coding RNAs (ncRNAs) are increasingly recognized as mediators of intercellular communication within the tumor microenvironment (TME), yet their mechanistic and translational significance varies substantially across gastrointestinal and hepatobiliary cancers. This narrative revi...

T. Alramadneh, Waleed K. Abdulsahib, Sanan Thaer Abdal-Wahab et al. · Cancer Treatment and Researc... · 0 citations

Review Jul 2026

EXPRESS: Circular RNAs as Next Generation Biomarkers for Minimal Residual Disease: Mechanistic Insights and Clinical Translation.

Minimal residual disease (MRD) denotes the persistence of malignant cells below the detection limits of conventional diagnostics and is a principal determinant of relapse and therapeutic failure. Enhancing MRD detection is therefore essential for precision oncology. Tumor‑derived circular RNAs (circRNAs)-covalently clo...

T. N. Alramadneh, Hussein salim abed, Sarah Qutayba Badraldin Qutayba Badraldin et al. · Journal of Investigative Med... · 0 citations